These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


727 related items for PubMed ID: 9447418

  • 21. [HIVAb, HCVAb and HBsAg seroprevalence among inmates of the prison of Bologna and the effect of counselling on the compliance of proposed tests].
    Sabbatani S, Giuliani R, Fulgaro C, Paolillo P, Baldi E, Chiodo F.
    Epidemiol Prev; 2004; 28(3):163-8. PubMed ID: 15532873
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey.
    Long J, Allwright S, Barry J, Reynolds SR, Thornton L, Bradley F, Parry JV.
    BMJ; 2001 Nov 24; 323(7323):1209-13. PubMed ID: 11719410
    [Abstract] [Full Text] [Related]

  • 23. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study.
    Quan VM, Go VF, Nam le V, Bergenstrom A, Thuoc NP, Zenilman J, Latkin C, Celentano DD.
    AIDS Care; 2009 Jan 24; 21(1):7-16. PubMed ID: 19085215
    [Abstract] [Full Text] [Related]

  • 24. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
    Liu Y, Liu Y, Zou X, Chen W, Ling L.
    BMJ Open; 2017 Jul 13; 7(7):e015524. PubMed ID: 28710214
    [Abstract] [Full Text] [Related]

  • 25. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
    Nasir A, Todd CS, Stanekzai MR, Bautista CT, Botros BA, Scott PT, Strathdee SA, Tjaden J.
    Int J Drug Policy; 2011 Mar 13; 22(2):145-52. PubMed ID: 21146392
    [Abstract] [Full Text] [Related]

  • 26. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study.
    Altawalah H, Essa S, Ezzikouri S, Al-Nakib W.
    Sci Rep; 2019 Apr 18; 9(1):6292. PubMed ID: 31000775
    [Abstract] [Full Text] [Related]

  • 27. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
    Santana Rodríguez OE, Malé Gil ML, HernándezSantana JF, Limiñana Cañal JM, Martín Sánchez AM.
    Eur J Epidemiol; 1998 Sep 18; 14(6):555-61. PubMed ID: 9794122
    [Abstract] [Full Text] [Related]

  • 28. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy.
    Guadagnino V, Zimatore G, Izzi A, Caroleo B, Rocca A, Montesano F, Costa C, Masciari R, Naso E, Biselli R.
    J Clin Lab Immunol; 1995 Sep 18; 47(1):1-9. PubMed ID: 8735431
    [Abstract] [Full Text] [Related]

  • 29. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour.
    Rhodes T, Hunter GM, Stimson GV, Donoghoe MC, Noble A, Parry J, Chalmers C.
    Addiction; 1996 Oct 18; 91(10):1457-67. PubMed ID: 8917914
    [Abstract] [Full Text] [Related]

  • 30. [Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen].
    Fuglsang T, Fouchard JR, Ege PP.
    Ugeskr Laeger; 2000 Jul 03; 162(27):3860-4. PubMed ID: 10920701
    [Abstract] [Full Text] [Related]

  • 31. Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA.
    Samuel MC, Doherty PM, Bulterys M, Jenison SA.
    Epidemiol Infect; 2001 Dec 03; 127(3):475-84. PubMed ID: 11811881
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Infection with human immunodeficiency virus and hepatitis viruses in Chinese drug addicts.
    Baozhang T, Kaining Z, Jinxing K, Ruchang X, Ming L, Caixia Z, Li T.
    Epidemiol Infect; 1997 Dec 03; 119(3):343-7. PubMed ID: 9440438
    [Abstract] [Full Text] [Related]

  • 36. Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada.
    Wylie JL, Shah L, Jolly AM.
    BMC Public Health; 2006 Sep 13; 6():229. PubMed ID: 16970811
    [Abstract] [Full Text] [Related]

  • 37. Transfusion-transmitted infections among multi-transfused patients in Brazil.
    de Paula EV, Gonçales NS, Xueref S, Addas-Carvalho M, Gilli SC, Angerami RN, Veríssimo MP, Gonçales FL.
    J Clin Virol; 2005 Dec 13; 34 Suppl 2():S27-32. PubMed ID: 16461237
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 37.